| Cat. No. |
Product Name |
Information |
| PC-45330 |
Bethoxazin
Microbicide
|
Bethoxazin is a broad spectrum industrial microbicide with applications in material and coating preservation. |
| PC-42715 |
Delamanid
|
Delamanid (OPC-67683) is a mycolic acid biosynthesis inhibitor found to be free of mutagenicity and to possess highly potent activity against tuberculosis, including MDR-TB. |
| PC-45307 |
Azithromycin
Antibiotic
|
Azithromycin (CP 62993) is a macrolide antibiotic used for the treatment of a number of bacterial infections. |
| PC-45263 |
Azathramycin
Antibiotic
|
Azathramycin is a macrolide antibiotic that effectively inhibits tumor angiogenesis by suppressing VEGFR2-mediated signaling pathways in lung cancer. |
| PC-45638 |
Ribocil-C
FMN riboswitch inhibitor
|
Ribocil-C is a highly selective inhibitor of the FMN riboswitch that controls expression of de novo riboflavin (Vitamin B2) biosynthesis in Escherichia coli. |
| PC-45926 |
Moxifloxacin
Antibiotic
|
Moxifloxacin is a fourth-generation synthetic fluoroquinolone, broad-spectrum antibacterial agent that is active against both Gram-positive and Gram-negative bacteria; inhibits DNA gyrase and topoisomerase IV. |
| PC-42665 |
Gatifloxacin
Bacterial DNA gyrase inhibitor
|
Gatifloxacin (PD 135432, AM1155) is a fourth-generation fluoroquinolone antibiotic that inhibits the bacterial DNA gyrase and topoisomerase IV. |
| PC-42048 |
Faropenem daloxate
Beta-lactam antibiotic
|
Faropenem daloxate (Faropenem medoxil) is a daloxate ester prodrug of Faropenem with broad-spectrum antibacterial activity against many gram-positive and gram-negative aerobes and anaerobes, a beta-lactam antibiotic. |
| PC-42714 |
Pretomanid
Mtb inhibitor
|
Pretomanid (PA-824) is an anti-tuberculosis agent that inhibits the synthesis of protein and cell wall lipid. |
| PC-25839 |
(S)-(-)-Acidomycin
BioB inhibitor
|
(S)-(-)-Acidomycin is a promising antitubercular activity against a series of contemporary drug susceptible and drug-resistant M. tuberculosis strains with MICs of 0.096-6.2 uM, inhibits biotin synthesis with a Ki of approximately 1 μM through the competitive inhibition of biotin synthase (BioB). |
| PC-25838 |
Mycobacidin
BioB inhibitor
|
Mycobacidin (Acidomycin, Actithiazic acid) is a promising antitubercular activity against a series of contemporary drug susceptible and drug-resistant M. tuberculosis strains with MICs of 0.096-6.2 uM, inhibits biotin synthesis with a Ki of approximately 1 μM through the competitive inhibition of biotin synthase (BioB). |
| PC-25837 |
Amiclenomycin
BioA inhibitor
|
Amiclenomycin is a natural L-amino acid antibiotic that blocks the biosynthesis of biotin by inhibiting 7,8-diaminopelargonic acid synthase (BioA synthase, DAPAS), inhibits growth of microorganisms and is specific against mycobacteria in vitro. |